Literature DB >> 3876268

Role of T cells in preventing transmission of rodent malaria.

P G Harte, N C Rogers, G A Targett.   

Abstract

Transmission blocking immunity induced by microgamete vaccination is fully effective for at least 12 months. Passive transfer of immune T cells reduced transmission of a subsequent infection by 95%, the effect being partly due to a significant reduction in numbers of circulating gametocytes during the infection. This immunity was apparently independent of specific antibody, though these were produced within a few days after challenge infection and was mediated by a T cell of the GK1.5+, Ly 2.2 phenotype. Immune serum and immune T cells, administered together, showed a strong additive effect and blocked transmission completely.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3876268      PMCID： PMC1453662     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  20 in total

1.  Studies on Plasmodium gallinaceum. II. Factors in the blood of the vertebrate host influencing mosquito infection.

Authors:  D E EYLES
Journal:  Am J Hyg       Date:  1952-03

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  Immunisation against gametes and asexual erythrocytic stages of a rodent malaria parasite.

Authors:  K N Mendis; G A Targett
Journal:  Nature       Date:  1979-02-01       Impact factor: 49.962

4.  Spleen-derived mononuclear cell chemotactic factor in malaria infections: a possible mechanism for splenic macrophage accumulation.

Authors:  D J Wyler; J I Gallin
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  Immunofluorescence method suitable for large-scale application to malaria.

Authors:  A Voller; P O'Neill
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

6.  Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin.

Authors:  M G Mage; L L McHugh; T L Rothstein
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

7.  Killing of human malaria parasites by macrophage secretory products.

Authors:  A O Wozencraft; H M Dockrell; J Taverne; G A Targett; J H Playfair
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

8.  Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition.

Authors:  I A Clark; E J Wills; J E Richmond; A C Allison
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

9.  The role of the liver in immunity to blood-stage murine malaria.

Authors:  H M Dockrell; J B de Souza; J H Playfair
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

10.  Immune phagocytosis in murine malaria.

Authors:  H L Shear; R S Nussenzweig; C Bianco
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307
View more
  9 in total

1.  Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium berghei.

Authors:  N Tirawanchai; L A Winger; J Nicholas; R E Sinden
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

Review 2.  Transmission-Blocking Vaccines: Old Friends and New Prospects.

Authors:  Festus K Acquah; Joshua Adjah; Kim C Williamson; Linda E Amoah
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

3.  Long-term protection of squirrel monkeys (Saimiri sciureus) against Plasmodium falciparum challenge inoculations after various time intervals.

Authors:  C Roussilhon; T Fandeur; J P Dedet
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

Review 4.  Status of malaria vaccine research.

Authors:  G A Targett
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

Review 5.  Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings.

Authors:  Charles Mulamba; Chris Williams; Katharina Kreppel; Jean Bosco Ouedraogo; Ally I Olotu
Journal:  Malar J       Date:  2022-06-02       Impact factor: 3.469

6.  Boosting of transmission-blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection.

Authors:  M B Ranawaka; Y D Munesinghe; D M de Silva; R Carter; K N Mendis
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

7.  A whole parasite transmission-blocking vaccine for malaria: an ignored strategy.

Authors:  Michael F Good; Stephanie K Yanow
Journal:  Emerg Top Life Sci       Date:  2017-12-22

Review 8.  Immune Responses to the Sexual Stages of Plasmodium falciparum Parasites.

Authors:  Jonas A Kengne-Ouafo; Colin J Sutherland; Fred N Binka; Gordon A Awandare; Britta C Urban; Bismarck Dinko
Journal:  Front Immunol       Date:  2019-02-11       Impact factor: 7.561

Review 9.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.